RecruitingNANCT04515810

Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning

Sponsor: Fred Hutchinson Cancer Center

Trial Details

ConditionLocally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Hematologic Malignancy, Refractory Hematologic Malignancy
InterventionInternet-Based Intervention; Best Practice; Telephone-Based Intervention; Questionnaire Administration; Post-intervention qualitative feedback interview
PhaseNA
StatusRecruiting
Participants400
Est. Completion31 Aug 2026
Last Updated26 June 2026

Primary Outcome

Feasibility: Accrual rates [Patients]; Feasibility: Accrual rates [Support persons]; Feasibility: Rates of intervention completion [Patients]; Feasibility: Rates of intervention completion [Support persons]; Acceptability of the PACT application: Acceptability E-Scale [Patients]; Acceptability of the PACT application: Acceptability E-Scale [Support persons]; Usability of the PACT application: System Usability Scale (SUS) [Patients]; Usability of the PACT application: System Usability Scale (SUS) [Support persons]; User satisfaction [Patients]; User satisfaction [Support persons]; User engagement as measured by number of views [Patients]; User engagement as measured by number of views [Support persons]; User engagement as measured by time spent on app [Patients]; User engagement as measured by time spent on app [Support persons]; Change in level of engagement in advance care planning [Patients]; Change in level of engagement in advance care planning [Patients]; Change in level of engagement in advance care planning [Support persons]; Change in level of engagement in advance care planning [Support persons]; Change in documentation of advance care planning conversations [Patients]; Change in documentation of advance care planning conversations [Patients]; Change in documentation of advance care planning conversations [Support persons]; Change in documentation of advance care planning conversations [Support persons]; Change in completion of advance directives; Change in completion of advance directives

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic solid cancer and/or disease progression following at least first line systemic therapy and/or relapsed or refractory hematologic cancer. * PATIENT: Have internet access through a computer or a mobile device; the principal investigator (PI) will ensure that those who have access to a computer or mobile device have access to a computer or mobile device with internet access to ensure they can complete study procedures. * PATIENT: The ability to provide informed consent. * PATIENT: Identification of a loved support person if one is available; patients who are unable to identify a support person willing to participate with them will be allowed to continue in the study on their own. * PATIENT: 18 years of age or older. * SUPPORT PERSON: The person (family member or friend) whom the patient indicates being a support person. * SUPPORT PERSON: English speaking. * SUPPORT PERSON: 18 years of age or older and able to provide informed consent. * PROVIDER: Current clinical practice and/or research with advanced cancer patients. * PROVIDER: A history of 3+ years working with advanced cancer patients. * PROVIDER: 18 years of age or older. Providers across disciplines (e.g., social work, oncology) will be enrolled. Exclusion Criteria: * PATIENT: Not fluent in English. * PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of \>= 6) to be delivered by trained study research staff during screening. * PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer). * PATIENT: Currently receiving hospice at the time of enrollment. * PATIENT: Children and young adults under age 18.

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service